---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-030456"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2026-09-15T20:44:10+00:00"
generated_at: "2026-09-15T20:45:49.416037+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences signs new $85M ATM equity program with Mizuho, ends TD Cowen ATM

## Summary
- New equity distribution agreement with Mizuho allows up to $85M in common stock sales; commission up to 3.0%.
- As of Sep 14, 2026, 1.38M shares sold under prior Aug 2026 Mizuho ATM, raising ~$68.8M of $75M limit.
- Terminated TD Cowen distribution agreement with ~$1.0M unsold; effective Sep 14, 2026.
- Sales via at-the-market offerings on Nasdaq under S-3 shelf (File 333-293596) effective Feb 27, 2026.

## SEC filing metadata
- accession: 0001437749-26-030456
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2026-09-15T20:44:10+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774926030456/0001437749-26-030456-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926030456/plse20260914_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-030456
- JSON: https://secwatch.observer/filing/0001437749-26-030456.json
- Plain text: https://secwatch.observer/filing/0001437749-26-030456.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.